MSB 3.19% 97.0¢ mesoblast limited

Is it our HF clinical trial (NCT04476901), primary completion...

  1. 797 Posts.
    lightbulb Created with Sketch. 93
    Is it our HF clinical trial (NCT04476901), primary completion 12/2025

    https://clinicaltrials.gov/study/NCT04476901?intr=Mesenchymal%20stem%20cells%20bone%20marrow&aggFilters=status:act%20rec%20not&locStr=USA&country=United%20States&page=3&rank=21

    The principle investigator, Joshua M Hare has association with Mesoblast.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.030(3.19%)
Mkt cap ! $1.110B
Open High Low Value Volume
94.0¢ 98.0¢ 92.0¢ $3.342M 3.477M

Buyers (Bids)

No. Vol. Price($)
4 33313 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 73982 2
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.